{"id":"NCT01365156","sponsor":"M.D. Anderson Cancer Center","briefTitle":"Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix","officialTitle":"A Phase III Randomized Study of Pretherapeutic Para-aortic Lymphadenectomy in Women With Locally Advanced Cervical Cancer Dispositioned to Definitive Chemoradiotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-08","primaryCompletion":"2020-01-24","completion":"2020-01-24","firstPosted":"2011-06-03","resultsPosted":"2021-02-03","lastUpdate":"2021-02-03"},"enrollment":28,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Cervical Squamous Cell Carcinoma","Adenosquamous Carcinoma","Adenocarcinoma","Locally Advanced Malignant Neoplasm","Cervical Cancer"],"interventions":[{"type":"PROCEDURE","name":"Extraperitoneal laparoscopic lymphadenectomy (EPLND)","otherNames":["Laparoscopic Extraperitoneal lymphadenectomy","Extraperitoneal Para-aortic Lymph Node Dissection","EPLND"]},{"type":"RADIATION","name":"Chemoradiation","otherNames":[]}],"arms":[{"label":"EPLND + Chemoradiation","type":"EXPERIMENTAL"},{"label":"Chemoradiation","type":"ACTIVE_COMPARATOR"}],"summary":"The goal of this clinical research study is to learn if a surgical procedure called an extraperitoneal laparoscopic lymphadenectomy followed by chemotherapy and tailored radiation therapy can help to control the disease for a longer time than standard-of-care chemotherapy and whole pelvic radiation therapy.","primaryOutcome":{"measure":"Overall Survival Rate","timeFrame":"3 years","effectByArm":[],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":3,"countries":["United States","Belgium"]},"refs":{"pmids":[],"seeAlso":["http://www.mdanderson.org"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":14},"commonTop":["Diarrhea","Nausea","Dyspareunia","Constipation","Vomiting"]}}